MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · American journal of translational research · 2018

Diwu Yanggan capsule improving liver histological response for patients with HBeAg-negative chronic hepatitis B: a randomized controlled clinical trial.

Li Hanmin, Ye Zhihua, Gao Xiang, Zhang Lisheng, Yao Xin, Gu Jianxun, Lu Dingbo, Wan Ming, Xiao Lin, Cai Wangxi, Yan Xuesheng, Zhao Binbin, Wu Yu, Zhang Jinrong

СтатьяПеревод в очереди

Аннотация

The number of patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) has shown a significant upward trend in recent years. However, antiviral drugs are not very effective. Regulation of liver regeneration by traditional Chinese medicine is an important way to improve clinical efficacy. This randomized controlled trial assessed the efficacy and safety of DWYG in patients with HBeAg-negative CHB. Overall, 130 subjects were randomized to (A) DWYG 1.2 g three times daily (n = 44), (B) entecavir 0.5 mg/day (n = 43) in combination with DWYG or (C) entecavir 0.5 mg/day (n = 43). The liver histological response rate was assessed as the primary efficacy endpoint. The results showed that the liver histological response rate in the combination treatment group was significantly higher than that in the group with entecavir (71.43% versus 22.22%; P = 0.036) after 48 weeks of treatment. And the pathological progression rate of liver in the group with DWYG was significantly lower than that of the entecavir group during 228 weeks of follow-up (0% versus 60.00%; P = 0.019). No significant adverse events occurred during the study. In conclusion, treating HBeAg-negative CHB with DWYG is safe and effective to improve liver histological response.

Для цитирования: Li Hanmin, Ye Zhihua, Gao Xiang, Zhang Lisheng, Yao Xin, Gu Jianxun, Lu Dingbo, Wan Ming, Xiao Lin, Cai Wangxi, Yan Xuesheng, Zhao Binbin, Wu Yu, Zhang Jinrong. Diwu Yanggan capsule improving liver histological response for patients with HBeAg-negative chronic hepatitis B: a randomized controlled clinical trial.. American journal of translational research. 2018.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.